Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinoic acid topical formulation development for acne
RBR-3t5ts4Phase 1Completed
- Sponsor
- Faculdade de Farmácia da UFMG
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tretinoin in acne vulgaris (12 arms), sponsored by Faculdade de Farmácia da UFMG. Primary endpoint: Transepidermal water loss. Started Sep 2018; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on RBR-3t5ts4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3t5ts4.